$BBLGW

AFH ACQUISITION X, INC.

CIK:0001419554|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenues
Operating expenses
Research and development	308,747	191,608	450,344	615,186
General and administrative	499,359	556,467	1,162,816	1,171,377
Total operating expenses	808,106	748,075	1,613,160	1,786,563
Loss from operations	(808,106)	(748,075)	(1,613,160)	(1,786,563)
Other income (expense)
Change in fair value of warrant liability	(108)	902	157	2,257
Interest income	34,512	6,654	73,313	26,695
Total other income	34,404	7,556	73,470	28,952
Net Loss	$ (773,702)	$ (740,519)	$ (1,539,690)	$ (1,757,611)
Weighted average shares outstanding - basic	1,796,755	557,787	1,796,012	544,277
Weighted average shares outstanding - diluted	1,796,755	557,787	1,796,012	544,277
Loss per share - basic	$ (0.43)	$ (1.33)	$ (0.86)	$ (3.23)
Loss per share - diluted	$ (0.43)	$ (1.33)	$ (0.86)	$ (3.23)

Condensed Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net loss	$ (1,539,690)	$ (1,757,611)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	31,758	123,504
Change in fair value of warrant liability	(157)	(2,257)
Changes in operating assets and liabilities:
Advances on research and development contract services		49,087
Prepaid insurance	106,682	125,403
Interest receivable	2,909
Prepaid financing costs	(52,666)
Accounts payable and accrued expenses	128,442	76,870
Net cash used in operating activities	(1,322,722)	(1,385,004)
Cash flows from financing activities
Proceeds from issuance of common shares from ATM, net of costs	20,180	347,549
Proceeds from sale of common stock and warrants in public offering, net of offering costs		4,352,792
Net cash provided by financing activities	20,180	4,700,341
Net increase (decrease) in cash	(1,302,542)	3,315,337
Cash, beginning of period	5,334,322	3,325,131
Cash, end of period	4,031,780	6,640,468
Supplemental information
Income taxes paid
Noncash investing and financing activities
Options issued to settle accrued bonus	$ 34,854	$ 46,183

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets
Cash	$ 4,031,780	$ 5,334,322
Advances on research and development contract services	208,972	208,972
Prepaid insurance	126,264	232,946
Prepaid financing costs	52,666
Interest Receivable	6,986	9,895
Prepaid expenses	10,000	10,000
Total current assets	4,436,668	5,796,135
Total assets	4,436,668	5,796,135
Current Liabilities
Accounts payable and accrued expenses	511,472	417,884
Warrant liability	546	703
Total current liabilities	512,018	418,587
Total liabilities	512,018	418,587
Commitments and Contingencies
Stockholders’ Equity
Preferred Stock, $0.001 par value per share; 20,000,000 shares authorized; none issued or outstanding at June 30, 2026 and December 31, 2025
Common stock, $0.001 par value per share; 100,000,000 shares authorized; 1,810,380 and 1,795,260 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	1,810	1,795
Additional paid-in capital	93,592,899	93,506,122
Accumulated deficit	(89,670,059)	(88,130,369)
Total stockholders’ equity	3,924,650	5,377,548
Total liabilities and stockholders’ equity	$ 4,436,668	$ 5,796,135